Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Contineum Therapeutics (CTNM) Depreciation & Amortization (CF) (2023 - 2026)

Contineum Therapeutics' Depreciation & Amortization (CF) history spans 4 years, with the latest figure at $83000.0 for Q1 2026.

  • Quarterly Depreciation & Amortization (CF) rose 6.41% to $83000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $305000.0 through Mar 2026, down 3.79% year-over-year, with the annual reading at $300000.0 for FY2025, 0.0% changed from the prior year.
  • Depreciation & Amortization (CF) came in at $83000.0 for Q1 2026, up from $62000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $117000.0 in Q4 2024 to a low of $37000.0 in Q4 2023.
  • The 4-year median for Depreciation & Amortization (CF) is $62000.0 (2024), against an average of $67538.5.
  • Year-over-year, Depreciation & Amortization (CF) surged 216.22% in 2024 and then tumbled 47.01% in 2025.
  • Contineum Therapeutics' Depreciation & Amortization (CF) stood at $37000.0 in 2023, then soared by 216.22% to $117000.0 in 2024, then crashed by 47.01% to $62000.0 in 2025, then soared by 33.87% to $83000.0 in 2026.
  • Per Business Quant, the three most recent readings for CTNM's Depreciation & Amortization (CF) are $83000.0 (Q1 2026), $62000.0 (Q4 2025), and $81000.0 (Q3 2025).